Food

Square Register Raises the Bar for Irish Businesses with a New, Comprehensive Point-of-Sale Solution

Retrieved on: 
Monday, May 16, 2022 - 8:07am
Other Retail, Consumer Electronics, Technology, Professional Services, Health, Food, Beverage, Other Technology, Retail, Other Professional Services, Hardware, Finance, Cream, Online, POS, Central Bank of Ireland, Environment, Multimedia, Solution, VAT, Restaurant, Commerce, Ice cream, Freedom, Technology, Central bank, Hardware, Ecosystem, Sale, USB, Clayton Square Shopping Centre, Mark (given name), NYSE, Computer data storage, Cryptocurrency, Online shopping, Square

Today, Square has launched its latest hardware offering, Square Register, a fully integrated countertop point-of-sale (POS) solution, designed to give Irish businesses with complex needs the versatility they need to manage sophisticated operations.

Key Points: 
  • Today, Square has launched its latest hardware offering, Square Register, a fully integrated countertop point-of-sale (POS) solution, designed to give Irish businesses with complex needs the versatility they need to manage sophisticated operations.
  • Square Register brings together modern hardware, embedded POS software that includes delivery and online order management, and Squares secure payment technology.
  • Register also runs Squares vertical POS software, Square for Retail and Square for Restaurants.
  • Were excited to be launching Square Register in Ireland, said Mike MacLennan, Head of Hardware at Square.

Despite A Rough Two Years, U.S. Independent Restaurants Still Represent Over Half of U.S. Commercial Restaurant Units and Are Recovering

Retrieved on: 
Monday, May 16, 2022 - 8:00am
Census, City, Sport, Beauty, Food, Book, APAC, Restaurant, The NPD Group, Video, NPD, Election, Twitter

CHICAGO, May 16, 2022 /PRNewswire-PRWeb/ -- Despite bearing the brunt of the pandemic dining room lockdowns and restrictions, independent restaurants with one to two locations still represent 53% of total restaurants in the U.S., reports The NPD Group. Independent restaurant locations declined by 8% or 28,399 units in 2020 but grew by 1% or 2,893 units by late 2021, according to NPD's Fall 2021 ReCount® restaurant census, which counts restaurants opened as of September 30, 2021. Independent locations are growing in seven of the nine Census divisions and large urban areas like Los Angeles, Dallas-Fort Worth, and Seattle-Tacoma.

Key Points: 
  • CHICAGO, May 16, 2022 /PRNewswire-PRWeb/ -- Despite bearing the brunt of the pandemic dining room lockdowns and restrictions, independent restaurants with one to two locations still represent 53% of total restaurants in the U.S., reports The NPD Group.
  • Independent restaurant locations declined by 8% or 28,399 units in 2020 but grew by 1% or 2,893 units by late 2021, according to NPD's Fall 2021 ReCount restaurant census , which counts restaurants opened as of September 30, 2021.
  • Independent locations are growing in seven of the nine Census divisions and large urban areas like Los Angeles, Dallas-Fort Worth, and Seattle-Tacoma.
  • Another sign of recovery is independent restaurant operators who purchase enough volume to order from broadline foodservice distributors have increased their spending and orders.

QIMA Joins the United Nations Global Compact Initiative

Retrieved on: 
Monday, May 16, 2022 - 8:00am
UN Global Counter-Terrorism Strategy, United Nations Global Compact, Sustainable Development Goals, Certification, Food, Disclosure, Environment, Goal, UN, Sustainable Development Goals and Lebanon, Quality control, Intelligence, CEO, Renewable energy, Management

HONG KONG, May 16, 2022 /PRNewswire/ -- QIMA , a leading provider of quality control and supply chain compliance solutions is pleased to announce their participation in the United Nations Global Compact initiative a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.

Key Points: 
  • HONG KONG, May 16, 2022 /PRNewswire/ -- QIMA , a leading provider of quality control and supply chain compliance solutions is pleased to announce their participation in the United Nations Global Compact initiative a voluntary leadership platform for the development, implementation and disclosure of responsible business practices.
  • With this announcement, QIMA is proud to join thousands of other companies globally committed to taking responsible business action to create the world peoplewant.
  • "At QIMA, our mission is to help our clients make products consumers can trust.
  • "By communicating our commitment and best practices through UN Global compact's principles, we are imposing on ourselves to be a positive contributor for a more sustainable global trade environment."

Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis

Retrieved on: 
Monday, May 16, 2022 - 5:05am
Epithelium, DDR1, Fibroblast, Private Securities Litigation Reform Act, Food, Survival, U.S. Securities and Exchange Commission, Patient, NASDAQ, ROCK2, CYP11B2, Prescription, COVID-19, PDGF, Cell, Kidney, FDA, IND, DDR2, Plasma, Fibrosis, Safety, Pathology, Degenerative disease, Lung, Therapy, Security (finance), Idiopathic pulmonary fibrosis, IPF, PK, Arm, Investigational New Drug, GLOBE, Pharmaceutical industry, Vaccine

UNIONDALE, N.Y., May 16, 2022 (GLOBE NEWSWIRE) -- Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today announced U.S. Food and Drug Administration’s (FDA) acceptance of an Investigational New Drug (IND) application supporting the clinical development of ANG-3070 in idiopathic pulmonary fibrosis (IPF) and clearance to begin a Phase 1b study of ANG-3070 in patients with IPF.

Key Points: 
  • IPF patients eligible for this Phase 1b study of ANG-3070 include those who have discontinued nintedanib or pirfenidone, refused treatment with nintedanib or pirfenidone, or those who are treatment nave.
  • Approximately 20 IPF patients will be enrolled into a crossover design trial with four arms dosing for ten days each.
  • A Phase 1b trial of ANG-3070 in patients with idiopathic pulmonary fibrosis is targeted to enroll and report data in 2022.
  • A Phase 1b trial of ANG-3070 in patients with idiopathic pulmonary fibrosis is targeted to enroll and report data in 2022.

HSA Group: urgent solutions needed to avert food import shortages and further humanitarian crisis in Yemen

Retrieved on: 
Monday, May 16, 2022 - 4:00am
HSA, Risk, History, IPC, Bread, Food, Woman, Insurance, Building material, UN, Private sector, WFP, World Food Programme, Philosophy, Food security, Time, Society, Famine, International Finance Corporation, Reward, Malnutrition, Face, Hunger, Growth, Agriculture, Bank, Coffee, Renewable energy, Dietary supplement

DUBAI, UAE, May 16, 2022 /PRNewswire/ -- HSA Group - Yemen's largest company and the country's leading wheat importer - has issued a stark warning that time is running out to avert a potentially catastrophic famine from spreading across Yemen, as a result of unprecedented disruption to global wheat supplies generated by the fallout from the conflict in Ukraine.

Key Points: 
  • Without urgent action, the latest developments have the potential to push Yemen's ongoing food security crisis to the point of no return.
  • Global wheat prices have recently reached a 14-year high, which is already having massive consequences for suppliers and manufacturers across the world.
  • Yemen is facing the prospect of food affordability and global supply chain challenges on a scale not seen before.
  • Yemen is suffering a grave food security crisis and the threat of extreme hunger and life-threatening malnutrition in Yemen has deteriorated further this year.

HSA Group: urgent solutions needed to avert food import shortages and further humanitarian crisis in Yemen

Retrieved on: 
Monday, May 16, 2022 - 4:00am
HSA, Risk, History, IPC, Bread, Food, Woman, Insurance, Building material, UN, Private sector, WFP, World Food Programme, Philosophy, Food security, Time, Society, Famine, International Finance Corporation, Reward, Malnutrition, Face, Hunger, Growth, Agriculture, Bank, Coffee, Renewable energy, Dietary supplement

DUBAI, UAE, May 16, 2022 /PRNewswire/ -- HSA Group - Yemen's largest company and the country's leading wheat importer - has issued a stark warning that time is running out to avert a potentially catastrophic famine from spreading across Yemen, as a result of unprecedented disruption to global wheat supplies generated by the fallout from the conflict in Ukraine.

Key Points: 
  • Without urgent action, the latest developments have the potential to push Yemen's ongoing food security crisis to the point of no return.
  • Global wheat prices have recently reached a 14-year high, which is already having massive consequences for suppliers and manufacturers across the world.
  • Yemen is facing the prospect of food affordability and global supply chain challenges on a scale not seen before.
  • Yemen is suffering a grave food security crisis and the threat of extreme hunger and life-threatening malnutrition in Yemen has deteriorated further this year.

TJI Achieves a Successful Leap to International Market

Retrieved on: 
Monday, May 16, 2022 - 12:43am
TJI, International, Depreciation, Food, Hong Kong Tourism Board, Snack, Guangdong-Hong Kong-Macau Greater Bay Area, COVID-19, Mainland, Restaurant, Efficiency, Culture, Industry, Partnership, Stock exchange, Pressure, Board, Hong Kong Stock Exchange, Group, HKEX, Face, Drink, Growth, COVID, Pharmaceutical industry, Food delivery, Airline, Tutoring, Fast food, Hotel, Warehouse, Euromonitor International

Meanwhile, operating profit increased by 38.2% to HK$476.7 million, with operating profit margin improving by 1.7 percentage points to 20.9%.

Key Points: 
  • Meanwhile, operating profit increased by 38.2% to HK$476.7 million, with operating profit margin improving by 1.7 percentage points to 20.9%.
  • It also made swift decisions regarding restaurant operating hours, renovation projects and restaurant opening schedule by re-assessing the market needs.
  • While the past year has been a bumpy ride, TJI has demonstrated resilience and agility in face of unanticipated situations.
  • As market activities have started picking up again in Japan, TJI will keep expanding its network healthily to capture the market momentum with the robust support of its controlling shareholder, Toridoll Holdings Corporation.

HappyFresh Digitally Transforms Warehouse Capabilities With Blue Yonder

Retrieved on: 
Monday, May 16, 2022 - 1:00am
Supply Chain Management, Retail, Technology, Supermarket, Software, Food, Beverage, Blue Yonder, City, SGV, WMS, Supply chain, Walking, Workflow, COVID-19, APAC, Industry, Habit, Name, Growth, Warehouse, Pigment

To meet the increased demand for its services, HappyFresh , an online grocery startup company, digitally transformed its warehouse operations with Blue Yonder s warehouse management system (WMS) .

Key Points: 
  • To meet the increased demand for its services, HappyFresh , an online grocery startup company, digitally transformed its warehouse operations with Blue Yonder s warehouse management system (WMS) .
  • Blue Yonders WMS has allowed HappyFresh to manage its warehouse management operations more effectively.
  • With Blue Yonder, you can make more automated, profitable business decisions that deliver greater growth and re-imagined customer experiences.
  • Blue Yonder - Fulfill your Potential blueyonder.com
    Blue Yonder is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name Blue Yonder is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

Retrieved on: 
Monday, May 16, 2022 - 12:00am
Uveitis, BTK, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Psoriatic arthritis, National Medical Products Administration, U.S. Securities and Exchange Commission, Degenerative disease, Patient, HCM, Pharmacokinetics, COVID-19, FDA, Hope, Center for Drug Evaluation and Research, IND, SAN, CDE, Psoriasis, Affibody molecule, AIM, Center, Forward-looking statement, TEC, III, NMPA, Sustainable Stock Exchanges Initiative, Therapy, Private Securities Litigation Reform Act, Cancer, Ankylosing spondylitis, CEO, Pharmaceutical industry

Inmagene is developing the drug candidate to potentially treat immunological diseases.

Key Points: 
  • Inmagene is developing the drug candidate to potentially treat immunological diseases.
  • "This is the third IND clearance Inmagene has obtained since the beginning of 2022," said Dr. Jonathan Wang, Chairman and CEO of Inmagene.
  • IMG-004's improved activity, selectivity, and pharmacokinetic profile in preclinical studies compared to those of other BTK inhibitors point toward a best-in-class potential.
  • IMG-004 is a non-covalent, reversible small molecule inhibitor targeting Bruton's tyrosine kinase (BTK).

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

Retrieved on: 
Sunday, May 15, 2022 - 11:00pm
Inflammation, Pain, Autoimmunity, Orbit, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, National Medical Products Administration, Doctor of Philosophy, Zenas, Patient, Graves' ophthalmopathy, Therapy, Severe cognitive impairment, Pharmacokinetics, Degenerative disease, Eye, Trial of the century, IND, TED, Fibrosis, Safety, NMPA, Eyelid, LinkedIn, Steroid, Twitter, GLOBE, Pharmaceutical industry, Viridian, MD

The ZB001 IND submission to the NMPA marks a significant milestone for Zenas, said Hua Mu, MD, PhD, Chief Executive Officer at Zenas.

Key Points: 
  • The ZB001 IND submission to the NMPA marks a significant milestone for Zenas, said Hua Mu, MD, PhD, Chief Executive Officer at Zenas.
  • ZB001 has the potential to change the treatment paradigm for TED patients in China.
  • ZB001 is a differentiated humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) for the treatment of TED.
  • For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn .